[1]
Sailaja, K.A.; Sreelola, V. Preparation and characterization of diltiazem HCl loaded bovine serum albumin nanoparticles by desolvation technique. Pharm. Nanotechnol., 2016, 4(4), 308-315.
[2]
Sailaja, A.K.; Amareshwar, P.; Chakravarty, P. Different techniques for the preparation of nanoparticles using natural polymers and their applications. Int. J. Pharm. Pharm. Sci., 2011, 3(2), 45-50.
[3]
Jahangirian, Hossein A review of drug delivery systems based on nanotechnology and green chemistry: Green nanomedicine. Int. J. Nanomedicine, 2017, 12, 2957-2978.
[4]
Garud, A.; Singh, D.; Garud, N. Solid lipid nanoparticles (Sln): Method, characterization and applications. Int. Curr. Pharm. J., 2012, 1(11), 384-393.
[5]
Kumar, C.S.S.R.; Mohammad, F. Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. Adv. Drug Deliv. Rev., 2011, 63(9), 789-808.
[6]
Chan, Li. Development and validation of a method for determination of encapsulation efficiency of CPT-11/ DSPE-mPEG2000 nanoparticles. Med. Chem., 2016, 6, 345.
[7]
Duxfield, L.; Sultana, R.; Wang, R.; Englebretsen, V.; Deo, S.; Swift, S.; Rupenthal, I.; Al-Kassas, R. Development of gatifloxacin-loaded cationic polymeric nanoparticles for ocular drug delivery. Pharm. Dev. Technol., 2012, 21(2), 172-179.
[8]
Yang, F.; Liang, D.; Long, Jiang. F.; Xing Ni, Q. Magnetic lymphatic targeting drug delivery system using carbon nanotubes. Med. Hypotheses, 2008, 70(4), 765-767.
[9]
Goyal, K.; Koul, V.; Singh, Y.; Anand, A. Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: Trends and advances. Cent. Nerv. Syst. Agents Med. Chem., 2014, 14(1), 43-59.
[10]
Grau, M.J.; Kayser, O.; Muller, R.H. Nanosuspensions of poorly soluble drugs reproducibility of small-scale production. Int. J. Pharm., 2000, 196, 155-157.
[11]
Haijuan, K.; Deng, H.; Lei, Z. Preparation and characterization of hollow Fe3O4/SiO2 PEG-PLA nanoparticles for drug delivery. Engineering, 2013, 194-199.
[12]
Heidari, A. Pharmaceutical and analytical chemistry study of cadmium oxide (CdO) nanoparticles synthesis methods and properties as anti-cancer drug and its effect on human cancer cells. Pharm. Anal. Chem., 2016, 2, 113.
[13]
McInnes, I.B.; Schett, G. Mechanisms of disease, the pathogenesis of rheumatoid arthritis. N. Engl. J. Med., 2011, 4(8), 461-473.
[14]
Javadzadeh, Y.; Ahadi, F.; Davaran, S.; Mohammadi, G.; Sabzevari, A.; Adibkia, K. Preparation and physicochemical characterization of naproxen-plga nanoparticles. Colloids Surf. B Biointerfaces, 2010, 498-502.
[15]
Jawahar, N.; Meyyanathan, S.N. Polymeric nanoparticles for drug delivery and targeting: A comprehensive review. Int. J. Health Allied Sci., 2012, 1, 217-223.
[16]
Govan, J. Gun ko, Y.K. Recent advances in the application of magnetic nanoparticles as a support for homogeneous catalysts. Nanomaterials (Basel), 2014, 4(2), 222-241.
[17]
Kayser, O. Nanosuspensions for the formulation of aphidicolin to improve drug targeting effects against Leishmania infected macrophages. Int. J. Pharm., 2000, 196, 253-256.
[18]
Khan, K.; Rehman, S.; Rahman, H.U.; Khan, Q. Synthesis and application of magnetic nanoparticles. Nanomagnetism, 2011, 1, 136-153.
[19]
Ranjeet, K.; Baqee, A.A. Nanoparticle: An overview of preparation, characterization and applications. Int. Res. J. Pharm., 2013, 4(4), 47-57.
[20]
Breunig, M.; Bauer, S.; Goepferich, A. Polymers and nanoparticles: Intelligent tools for intracellular targeting. Eur. J. Pharm. Biopharm., 2008, 68(1), 112-128.
[21]
Dadwal, M. Polymeric nanoparticles as promising novel carriers for drug delivery: An overview. J. Adv. Pharm. Educ. Res., 2014, 4(1), 20-30.